5 Results

People

  1. Bewersdorf
    Bewersdorf
  2. Abdel-Wahab
    Abdel-Wahab
  3. Knorr
    Knorr
  4. Mato
    Mato
  5. Roeker
    Roeker
  6. Stein
    Stein
  7. Thompson
    Thompson
  8. Battiato
    Battiato
  9. Bourcier
    Bourcier
  10. Butala
    Butala

Groups

  1. Center for Hematologic Malignancies (5)
  2. Department of Medicine (5)
  3. GME, Medicine (5)
  4. Graduate Medical Education (5)
  5. Hematologic Malignancies, Division of (5)
  6. Hematology-Oncology Fellows (5)
  7. Adult Leukemia (4)
  8. Executive Committee, Center for Hematologic Malignancies (2)
  9. GSK Faculty (2)
  10. Human Oncology and Pathogenesis Program (2)
  1. "Nature Publishing Group"
  2. "Leukemia"
  3. "Department of Medicine"
  4. "Graduate Medical Education"
  5. "Hematology-Oncology Fellows"
Formats
  1. Research Letter (3)
  2. Editorial (1)
  3. Journal Article (1)
Groups
  1. Center for Hematologic Malignancies (5)
  2. Department of Medicine (5)
  3. GME, Medicine (5)
  4. Graduate Medical Education (5)
  5. Hematologic Malignancies, Division of (5)
  6. Hematology-Oncology Fellows (5)

More Groups

People
  1. Jan Bewersdorf (3)
  2. Anthony Mato (2)
  3. David Knorr (2)
  4. Eytan Stein (2)
  5. Lindsey Roeker (2)
  6. Meghan Thompson (2)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (1)
  4. 2021 (1)
  5. 2020 (1)
Publications
  1. Leukemia (5)
Publishers
  1. Nature Publishing Group (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML
    Journal Article

    Shimony, S.; Bewersdorf, J. P.; Shallis, R. M.; Liu, Y.; Schaefer, E. J.; Zeidan, A. M.; Goldberg, A. D.; Stein, E. M.; Marcucci, G.; Lindsley, R. C.; more...
    Leukemia (2024)

    Fulltext@MSK | Save
  • E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: A phase II clinical trial
    Research Letter

    Bewersdorf, J. P.; Stahl, M.; Taylor, J.; Mi, X.; Chandhok, N. S.; Watts, J.; Derkach, A.; Wysocki, M.; Lu, S. X.; Bourcier, J.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Finding consistency in classifications of myeloid neoplasms: A perspective on behalf of the International Workshop for Myelodysplastic Syndromes
    Editorial

    Zeidan, A. M.; Bewersdorf, J. P.; Buckstein, R.; Sekeres, M. A.; Steensma, D. P.; Platzbecker, U.; Loghavi, S.; Boultwood, J.; Bejar, R.; Bennett, J. M.; more...
    Leukemia (2022)

    Fulltext@MSK | Save
  • COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia
    Research Letter

    Roeker, L. E.; Knorr, D. A.; Thompson, M. C.; Nivar, M.; Lebowitz, S.; Peters, N.; Deonarine, I. Jr; Momotaj, S.; Sharan, S.; Chanlatte, V.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia
    Research Letter

    Roeker, L. E.; Knorr, D. A.; Pessin, M. S.; Ramanathan, L. V.; Thompson, M. C.; Leslie, L. A.; Zelenetz, A. D.; Mato, A. R.
    Leukemia (2020)

    Fulltext@MSK | Save